What are the recommended first-line intravenous antibiotics for an adult with acute sepsis of unknown source?

First-Line Antibiotics for Acute Sepsis

Administer empiric broad-spectrum intravenous antibiotics within one hour of recognizing sepsis or septic shock, using an extended-spectrum β-lactam as the backbone of therapy, with additional agents selected based on suspected source and local resistance patterns. 1

Core Antibiotic Strategy

The Surviving Sepsis Campaign guidelines provide the definitive framework for antibiotic selection in acute sepsis of unknown source:

Primary Backbone Agent (Extended-Spectrum β-Lactams)

Choose ONE of the following as your primary agent:

• Piperacillin-tazobactam 4.5g IV every 6-8 hours
• Cefepime 2g IV every 8 hours
• Meropenem 2g IV every 8 hours (if high risk for ESBL organisms)
• Ceftriaxone 2g IV every 12-24 hours (if lower acuity, no Pseudomonas risk)

These agents provide broad gram-negative and gram-positive coverage and are the foundation of empiric sepsis treatment 1.

When to Add Combination Therapy

For septic shock specifically, the guidelines suggest (weak recommendation) adding a second agent from a different class 1:

Add an aminoglycoside OR fluoroquinolone if:

• Patient is in septic shock with respiratory failure
• Pseudomonas aeruginosa is suspected
• Multidrug-resistant gram-negatives are prevalent locally

Specific combinations:

• Extended-spectrum β-lactam + gentamicin (5-7 mg/kg IV daily) OR
• Extended-spectrum β-lactam + ciprofloxacin (400mg IV every 8-12 hours)

Add a macrolide if:

• Septic shock with suspected pneumococcal bacteremia
• Community-acquired pneumonia is the suspected source

Specific combination:

• β-lactam + azithromycin (500mg IV daily)

MRSA Coverage

Add vancomycin (25-30 mg/kg IV loading dose, then 15-20 mg/kg every 8-12 hours) OR linezolid (600mg IV every 12 hours) if:

• Suspected catheter-related bloodstream infection
• Skin/soft tissue source with purulent drainage
• Known MRSA colonization
• High local MRSA prevalence in severe infections
• Recent hospitalization or healthcare exposure

1

Critical Timing and Administration Details

Time-to-antibiotics is non-negotiable:

• Septic shock: antibiotics within 1 hour (strong recommendation) 1, 2
• Sepsis without shock: antibiotics within 1 hour (strong recommendation) 1
• The 2024 NICE guidelines suggest up to 3 hours for moderate risk, but the Surviving Sepsis Campaign's 1-hour target remains the gold standard 2

Administration technique matters:

• Give β-lactams as a loading dose first (standard dose as rapid infusion)
• Consider extended infusion (over 3-4 hours) or continuous infusion for subsequent doses to optimize time above MIC 1
• Vancomycin requires a loading dose of 25-30 mg/kg to rapidly achieve therapeutic levels 1

Source-Specific Considerations

While the source is unknown initially, tailor coverage once suspected:

Abdominal source suspected:

• Ensure anaerobic coverage (piperacillin-tazobactam covers this; otherwise add metronidazole)

Urinary source suspected:

• Most β-lactams provide adequate coverage
• Consider local resistance patterns for E. coli and Klebsiella

Pneumonia suspected:

• Add macrolide (azithromycin) for atypical coverage
• Consider adding vancomycin or linezolid if MRSA pneumonia possible

Unknown source:

• Broad-spectrum β-lactam alone is reasonable for sepsis without shock
• Add MRSA coverage if risk factors present
• Add second gram-negative agent only if septic shock present

1

De-escalation Protocol

Critical pitfall to avoid: Continuing broad-spectrum or combination therapy longer than necessary.

• Reassess daily for de-escalation opportunities (strong recommendation) 1
• Discontinue combination therapy within 3-5 days once clinical improvement occurs 1
• Narrow to targeted therapy as soon as culture results and sensitivities are available 1
• Total duration typically 7-10 days for most infections; shorter courses appropriate with rapid source control 1

Common Pitfalls

1. Delaying antibiotics for cultures: Obtain blood cultures first, but never delay antibiotics beyond 45 minutes 1

2. Inadequate dosing in critically ill patients: Use loading doses and consider extended infusions; septic patients have altered pharmacokinetics 1

3. Routine combination therapy for all sepsis: Only indicated for septic shock; not for sepsis without shock (weak recommendation against routine use) 1

4. Prolonged empiric therapy: De-escalate within 3-5 days based on clinical response and cultures 1

5. Forgetting MRSA coverage in high-risk patients: Healthcare-associated infections and device-related infections require anti-MRSA therapy 1

Practical Algorithm

Step 1: Recognize sepsis/septic shock → Start clock (goal: antibiotics within 1 hour)

Step 2: Obtain blood cultures (at least 2 sets) immediately

Step 3: Choose extended-spectrum β-lactam based on:

• Local antibiogram
• Recent antibiotic exposure
• Healthcare vs. community-acquired

Step 4: Add MRSA coverage if risk factors present

Step 5: If septic shock: add second gram-negative agent (aminoglycoside or fluoroquinolone)

Step 6: Administer within 1 hour of recognition

Step 7: Reassess daily for de-escalation starting at 48-72 hours